FIXX
Homology Medicines Inc
Halal Rating :
Last Price
$3.28
Last updated:
Market Cap
-
7D Change
5.81%
1 Year Change
463.57%
Company Overview
Exchange
Next Earnings Date
Homology Medicines Inc is a genetic medicines company focused on developing treatments for rare genetic diseases. The company uses its proprietary platform technology, AMEnDR (Adeno-associated Virus Medicinal Gene Driver), to develop genetic medicines. Their approach includes gene therapy and gene editing to treat rare genetic diseases.
The company is currently in pre-revenue stage, primarily focused on research and development of its gene therapy candidates. Their pipeline includes treatments for phenylketonuria (PKU) and other rare genetic conditions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Homology Medicines Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.